Therapeutic effect of autologous platelet-rich plasma (PRP) on recalcitrant cutaneous ulcers in livedoid vasculopathy

[1]  R. Kirsner,et al.  Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. , 2013, Journal of the American Academy of Dermatology.

[2]  K. Lee,et al.  Application of platelet-rich plasma accelerates the wound healing process in acute and chronic ulcers through rapid migration and upregulation of cyclin A and CDK4 in HaCaT cells. , 2013, Molecular medicine reports.

[3]  M. Davis,et al.  Update of management of connective tissue diseases: livedoid vasculopathy , 2012, Dermatologic therapy.

[4]  D. Gater,et al.  A case report on the use of sustained release platelet-rich plasma for the treatment of chronic pressure ulcers , 2011, The journal of spinal cord medicine.

[5]  P. Criado,et al.  Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs – a prospective study , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  V. Santos,et al.  Evidence on the use of platelet-rich plasma for diabetic ulcer: A systematic review , 2010, Growth factors.

[7]  J. Callen.  Livedoid vasculopathy: what it is and how the patient should be evaluated and treated. , 2006, Archives of dermatology.

[8]  M. Pittelkow,et al.  Livedoid vasculopathy: further evidence for procoagulant pathogenesis. , 2006, Archives of dermatology.

[9]  P. Helmbold,et al.  Livedoid vasculitis with ulcerations: the role of antithrombin III deficiency and its therapeutic consequences. , 2002, Archives of dermatology.

[10]  W. White,et al.  Livedo vasculitis: vasculitis or thrombotic vasculopathy? , 1992, Clinical and experimental dermatology.